Floatz logo

Fludarabine

Ocular Melanoma

H. Lee Moffitt Cancer Center and Research InstituteSmall moleculePhase 2Active
B
59/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
44/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Ocular Melanoma cohort.

Asset / SponsorPhaseRating
BELZUPACAP SAROTALOCAN
Aura Biosciences
Phase 2BB
Ipilimumab
University of Michigan Rogel Cancer Center
Phase 2BB
Polyiclc
Craig L Slingluff, Jr
Phase 2B
Nivolumab
University of Michigan Rogel Cancer Center
Phase 2B
Aflibercept
Centre Hospitalier Universitaire de Nice
Phase 3B

View all 25 →

Same molecule, other indications

Fludarabine is also rated in:

acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →
Fanconi anemiaDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Adult Diffuse Large Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →